封面
市場調查報告書
商品編碼
1430035

元宇宙醫療保健市場規模:按技術、組件、應用程式、最終用戶 - 區域展望、競爭策略、細分市場預測(~2033 年)

Metaverse in Healthcare Market Size- By Technology, By Component, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 213 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2033 年,醫療元宇宙市場規模將成長至 1,274.6 億美元,預測期內複合年成長率為 29.61%。

元宇宙正在融合三個重要的技術趨勢:人工智慧、擴增實境(AR)和虛擬實境(VR)。它們共同有潛力擴大全新的治療選擇、降低成本並顯著改善患者的治療效果。

COVID-19 的爆發促使研究人員探索超越實體診所範圍遠端探望患者的方法。市場的成長也受到智慧型手機和穿戴式科技使用日益增加的影響。數位健康正在徹底改變醫療保健產業,並成為生物技術進步的根本和強大驅動力。

本報告調查了全球醫療保健元宇宙市場,並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭形勢和主要企業。我正在收集簡介等。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 促進因素、限制因素、機會與挑戰分析
  • COVID-19 對市場的影響

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭形勢

  • 製造地、銷售區域、產品類型分佈
  • 併購、聯盟、產品發布、合作

第7章全球醫療保健元宇宙市場:按組成部分

  • 全球市佔率及預測
  • 硬體
  • 服務
  • 軟體

第8章全球醫療保健元宇宙市場:依科技分類

  • 全球市佔率及預測
  • AI
  • AR/VR
  • 區塊鏈
  • IoT
  • MR

第9章全球醫療保健元宇宙市場:依應用分類

  • 全球市佔率及預測
  • 診斷
  • 醫療訓練/教育
  • 遠端醫療

第 10 章 全球醫療元宇宙市場:依最終使用者分類

  • 全球市佔率及預測
  • 病人
  • 保險公司
  • 藥局
  • 醫療提供者

第11章 全球醫療元宇宙市場預測

  • 市場規模/市場佔有率

第12章全球醫療保健元宇宙市場:按組成部分

  • 市場規模/市場佔有率趨勢/預測

第13章全球醫療保健元宇宙市場:依科技分類

  • 市場規模/市場佔有率趨勢/預測

第14章全球醫療保健元宇宙市場:依應用分類

  • 市場規模/市場佔有率趨勢/預測

第15章全球醫療元宇宙市場:依最終用戶分類

  • 市場規模/市場佔有率趨勢/預測

第16章全球醫療保健元宇宙市場:按地區

  • 市場規模/市場佔有率趨勢/預測
  • 亞太地區
  • 歐洲
  • 中東/非洲
  • 北美洲
  • 拉丁美洲

第17章 公司簡介

  • Brain lab
  • Medtronic PLC
  • Meta Platforms
  • Microsoft Corporation
  • Nvidia Corporation
  • Roblox Corporation
  • Sesame
  • Siemens Healthineers
  • Veyond Metaverse
  • Zimmer Biomet Holdings
  • 其他

第18章簡稱表

第19章 參考鏈接

第20章結論

第21章 研究範圍

簡介目錄
Product Code: IACT2425

Metaverse In Healthcare Market Introduction and Overview

According to SPER market research, 'Metaverse in Healthcare Market By Technology, By Component, By Application, By End User -Regional Outlook, Competitive Strategies and Segment Forecast to 2033 'state that the Metaverse In Healthcare Market is predicted to reach USD 127.46 billion by 2033 with a CAGR of 29.61%.

The huge digital cosmos known as the meta-verse coexists with the physical world. All of the virtual worlds that individuals can engage with, socialize in, play games, and shop in make up the meta-verse. In the meta-verse (VR), three key technological trends-intellectual (AI), augmented reality (AR), and virtual reality (VR)-converge. When combined, they have the potential to open up whole new treatment options, reduce expenses, and significantly improve patient outcomes.

The COVID-19 pandemic acted as a spur for researchers to discover methods for remote patient supervision beyond the confines of physical clinics. Growth in the market has also been impacted by the growing use of smartphones and wearable technology. One significant element in this context is digital health, which is revolutionizing the healthcare industry and acting as a fundamentally potent push for biotechnology advancement.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Component, By Technology, By Application, By End User

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Brain lab, Medtronic PLC, Meta Platforms, Microsoft Corporation, Nvidia Corporation, Roblox Corporation, Sesame, Siemens Healthineers, Veyond Metaverse, Zimmer Biomet Holdings

Metaverse In Healthcare Market Segmentation:

By Components: Based on the Components, Global Metaverse in Healthcare Market is segmented as Hardware, Services, Software.

By Technology: Based on the Technology, Global Metaverse in Healthcare Market is segmented as AR/VR, MR, AI, Blockchain, IoT.

By Application: Based on the Application, Global Metaverse in Healthcare Market is segmented as Tele-health, Diagnostics, Medical Training & Education.

By End-User: Based on the End-User, Global Metaverse in Healthcare Market is segmented as Provider, Patients, Payers, Pharmacy.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Metaverse In Healthcare Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Metaverse In Healthcare Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Metaverse In Healthcare Market

7. Global Metaverse In Healthcare Market, By Component (USD Million)

  • 7.1. Global Metaverse In Healthcare Market Value Share and Forecast, By Component 2023-2033
  • 7.2. Hardware
  • 7.3. Services
  • 7.4. Software

8. Global Metaverse In Healthcare Market, By Technology (USD Million)

  • 8.1. Global Metaverse In Healthcare Market Value Share and Forecast, By Technology 2023-2033
  • 8.2. AI
  • 8.3. AR/VR
  • 8.4. Block chain
  • 8.5. IoT
  • 8.6. MR

9. Global Metaverse In Healthcare Market, By Application (USD Million)

  • 9.1. Global Metaverse In Healthcare Market Size Value Share and Forecast, By Disease Stage 2023-2033
  • 9.2. Diagnostics,
  • 9.3. Medical Training & Education
  • 9.4. Tele-health

10. Global Metaverse In Healthcare Market, By End User (USD Million)

  • 10.1. Global Metaverse In Healthcare Market Size Value Share and Forecast, By Disease Stage 2023-2033
  • 10.2. Patients
  • 10.3. Payers
  • 10.4. Pharmacy
  • 10.5. Provider

11. Global Metaverse In Healthcare Market, Forecast, 2019-2033 (USD Million)

  • 11.1. Global Metaverse In Healthcare Market Size and Market Share

12. Global Metaverse In Healthcare Market, By Component 2019-2033 (USD Million)

  • 12.1. Global Metaverse In Healthcare Market Size and Market Share, By Component (2019-2026)
  • 12.2. Global Metaverse In Healthcare Market Size and Market Share, By Component (2027-2033)

13. Global Metaverse In Healthcare Market, By Technology 2019-2033 (USD Million)

  • 13.1. Global Metaverse In Healthcare Market Size and Market Share, By Technology (2019-2026)
  • 13.2. Global Metaverse In Healthcare Market Size and Market Share, By Technology (2027-2033)

14. Global Metaverse In Healthcare Market, By Application, 2019-2033 (USD Million)

  • 14.1. Global Metaverse In Healthcare Market Size and Market Share, By Application (2019-2026)
  • 14.2. Global Metaverse In Healthcare Market Size and Market Share, By Application (2027-2033)

15. Global Metaverse In Healthcare Market, By End User 2019-2033 (USD Million)

  • 15.1. Global Metaverse In Healthcare Market Size and Market Share, By End User (2019-2026)
  • 15.2. Global Metaverse In Healthcare Market Size and Market Share, By End User (2027-2033

16. Global Metaverse In Healthcare Market, By Region, 2019-2033 (USD Million)

  • 16.1. Global Metaverse In Healthcare Market Size and Market Share, By Region (2019-2026)
  • 16.2. Global Metaverse In Healthcare Market Size and Market Share, By Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. Brain lab
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Medtronic PLC
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Meta Platforms
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. Microsoft Corporation
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. Nvidia Corporation
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. Roblox Corporation
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. Sesame
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. Siemens Healthineers
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. Veyond Metaverse
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. Zimmer Biomet Holdings
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope